Latest market price
40.43
+0.43+1.07%
Earnings
Up 1.1% — Earnings due 2026-11-05 — pre-report positioning.
Medium confidence
TA
Loading chart...
Snapshot
| Index | — | P/E | 38.83 | EPS (ttm) | 1.03 | Insider Own | — | Shs Outstand | 63.32M | Perf Week | 2.07% |
| Market Cap | 2.53B | Forward P/E | 27.88 | EPS next Y | 1.43 | Insider Trans | 0.00% | Shs Float | 51.12M | Perf Month | -5.62% |
| Enterprise Value | 2.48B | PEG | 3.72 | EPS next Q | 0.31 | Short Float | 4.66% | Perf Quarter | -1.31% | ||
| Income | 66.00M | P/S | 1.73 | EPS this Y | 32.52% | Short Ratio | 4.84 | Perf Half Y | 9.17% | ||
| Sales | 1.46B | P/B | 9.82 | EPS next Y | 10.21% | ROA | 14.86% | Short Interest | 2.38M | Perf YTD | 32.93% |
| Book/sh | 4.07 | P/C | 28.14 | EPS next 5Y | 10.43% | ROE | 30.80% | 52W High | 48.33 -16.35% | Perf Year | 41.24% |
| Cash/sh | 1.42 | P/FCF | 32.06 | EPS past 3/5Y | 10.38% 18.77% | ROIC | 21.45% | 52W Low | 26.34 53.49% | Perf 3Y | — |
| Dividend Est. | — | EV/EBITDA | 20.65 | Sales past 3/5Y | 16.82% 14.51% | Gross Margin | 21.63% | Volatility | 2.71% 3.31% | Perf 5Y | — |
| Dividend TTM | — | EV/Sales | 1.69 | EPS Y/Y TTM | — | Oper. Margin | 6.27% | ATR (14) | 1.41 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 1.33 | Sales Y/Y TTM | 10.41% | Profit Margin | 4.50% | RSI (14) | 46.97 | Recom | 2.00 |
| Dividend Gr. 3/5Y | — | Current Ratio | 1.65 | EPS Q/Q | 26.09% | SMA20 | -0.62% | Beta | 0.53 | Target Price | 50.67 |
| Payout | 0.00% | Debt/Eq | 0.14 | Sales Q/Q | 2.33% | SMA50 | -2.66% | Rel Volume | 0.82 | Prev Close | 40.00 |
| Employees | 3,600 | LT Debt/Eq | 0.11 | Earnings | Nov 05 | SMA200 | 4.89% | Avg Volume | 501.72K | Price | 40.43 |
| IPO Date | Sep 26, 2024 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 10.83% 3.32% | Net Debt/EBITDA | -0.46 | Volume | 410,298 | Change | 1.07% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-22-26 | Initiated | KeyBanc | Overweight | $52 |
| Sep-21-26 | Reiterated | Truist Securities | Buy | $47 → $51 |
| Aug-07-26 | Reiterated | Oppenheimer | Outperform | $30 → $49 |
| Jun-17-26 | Reiterated | Truist Securities | Buy | $38 → $47 |
| Mar-12-26 | Reiterated | Raymond James | $28 → $40 | |
| Mar-12-26 | Reiterated | Truist Securities | Buy | $34 → $38 |
| Jan-14-26 | Reiterated | Stephens & Co. | Overweight | $36 |
| Nov-14-25 | Reiterated | Truist Securities | Buy | $30 → $34 |
| Oct-10-25 | Initiated | Oppenheimer | Outperform | $30 |
| Sep-26-25 | Reiterated | Truist Securities | Buy | $30 |
Latest News· Times ET
Nov-02-26
Nov-02-2604:30PM
04:30PM
Oct-24-26
Oct-24-2611:19PM
Oct-21-26
Oct-21-2604:30PM
Oct-12-26
Sep-29-26
Sep-28-26
Sep-21-26
Sep-21-2604:58AM
04:29AM
Sep-01-26
Sep-01-2604:30PM
Aug-29-26
Aug-29-2604:00AM
Aug-19-26
Aug-19-2604:30PM
Aug-13-26
Aug-08-26
Aug-07-26
Aug-07-2607:24AM
Company
Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,464 | 1,449 | 1,228 | 1,046 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,147 | 1,167 | 984 | 838 | — | — | — | — | — | |
| Gross Profit | 317 | 282 | 244 | 208 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 225 | 193 | 307 | 167 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Operating Income | 93 | 89 | -63 | 41 | — | — | — | — | — | |
| Interest Expense | 0 | 1 | 3 | 3 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 5 | -15 | 0 | 0 | — | — | — | — | — | |
| Net Income Before Taxes | 96 | 73 | -66 | 38 | — | — | — | — | — | |
| Income Taxes | 30 | 24 | 5 | 0 | — | — | — | — | — | |
| Consolidated Net Income | 66 | 49 | -87 | 24 | — | — | — | — | — | |
| Net Income From Continuing Operations | 67 | 49 | -71 | 38 | — | — | — | — | — | |
| Net Income | 66 | 49 | -87 | 24 | — | — | — | — | — | |
| EPS (Recurring) | 1.05 | 0.79 | -1.77 | 0.39 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.05 | 0.79 | -1.77 | 0.39 | — | — | — | — | — | |
| EPS (Diluted) | 1.03 | 0.78 | -1.77 | 0.39 | — | — | — | — | — | |
| EBITDA | 120 | 96 | -43 | 59 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 39.25 | 38.58 | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.74 | 1.29 | 1.02 | — | — | — | — | — | — | |
| Gross Margin | 21.65 | 19.46 | 19.87 | 19.89 | — | — | — | — | — | |
| Operating Margin | 6.35 | 6.14 | -5.13 | 3.92 | — | — | — | — | — | |
| Net Margin | 4.51 | 3.38 | -7.08 | 2.29 | — | — | — | — | — | |
| Shares Outstanding | 63 | 62 | 62 | 61 | — | — | — | — | — | |
| Market Capitalization | 2,547 | 1,866 | 1,256 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Weir Robert | Officer | Sep 27 '26 | Option Exercise | 0.00 | 23,450 | 0 | 103,333 | Sep 28 |
| Ackerman John | Director, Member of 10% Owner Group | Sep 27 '26 | Option Exercise | 0.00 | 1,884,996 | 0 | 3,863,806 | Sep 28 |
| Mudd William Franklin | Officer | Sep 27 '26 | Option Exercise | 0.00 | 38,282 | 0 | 136,747 | Sep 28 |
| Salentine Thomas J Jr | Director, 10% Owner, Member of 10% Owner Group | Sep 27 '26 | Option Exercise | 0.00 | 6,100,175 | 0 | 16,669,666 | Sep 28 |
| Martin David Norman | Officer | Sep 27 '26 | Option Exercise | 0.00 | 39,865 | 0 | 140,905 | Sep 28 |
| Pharmacy Investors, LLC | Member of 10% Owner Group | Sep 27 '26 | Option Exercise | 0.00 | 1,413,939 | 0 | 3,863,806 | Sep 28 |
| Burke Fred | Director, Officer | Sep 27 '26 | Option Exercise | 0.00 | 1,298,825 | 0 | 3,438,064 | Sep 28 |
| Tuch Jeffrey | Officer | Sep 27 '26 | Option Exercise | 0.00 | 55,578 | 0 | 231,847 | Sep 28 |
| Forbes Kendall | Member of 10% Owner Group | Sep 27 '26 | Option Exercise | 0.00 | 608,570 | 0 | 1,651,059 | Sep 28 |
| BINDLEY WILLIAM E | Director, 10% Owner, Member of 10% Owner Group | Sep 27 '26 | Option Exercise | 0.00 | 6,100,175 | 0 | 16,669,666 | Sep 28 |
| Morris David K | Director, Officer | Sep 27 '26 | Option Exercise | 0.00 | 641,870 | 0 | 896,341 | Sep 28 |
| Crisafulli Chris | Officer | Sep 27 '26 | Option Exercise | 0.00 | 18,931 | 0 | 53,057 | Sep 28 |
| Eakins Richard | Senior Vice President, Sales | Sep 27 '26 | Option Exercise | 0.00 | 36,052 | 0 | 134,930 | Sep 28 |
| Cardinal Equity Fund, L.P. | Member of 10% owner Group | Sep 27 '26 | Option Exercise | 0.00 | 471,057 | 0 | 1,287,237 | Sep 28 |
| Bindley Capital Partners I, LLC | 10% Owner, Member of 10% Owner Group | Sep 27 '26 | Option Exercise | 0.00 | 6,100,175 | 0 | 16,669,666 | Sep 28 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.